60
Views
18
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Adenocarcinoma of the prostate in Iceland: A population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987

, MD, , , , , , , & show all
Pages 265-271 | Received 01 Mar 2005, Published online: 09 Jul 2009

References

  • International Union Against Cancer. TNM classification of malignant tumours, 5th ed. Sobin LH, Wittekind Ch., editors. New York: Wiley-Liss; 1997.
  • Gleason DF, Mellinger GT, and The Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111:58–64.
  • Khalifa NM, Jarman WD. A study of 48 cases of incidental carcinoma of the prostate followed 10 years or longer. J Urol 1976; 116: 329–31
  • Barnes R, Hirst A, Rosenquist R. Early carcinoma of the prostate: comparison of stages A and B. J Urol 1976; 115: 404–405
  • Golimbu M, Morales P. Stage A 2 prostatic carcinoma. Should staging system be reclassified?. Urology 1979; 13: 592–96
  • Moller B, Fekjaer H, Hakulinen T, Tryggvadottir L, Storm HH, Talback M, et al. Prediction of cancer incidence in the Nordic countries up to the year 2020 [Review]. Eur J Cancer Prev 2002; (11 Suppl 1): S1–96
  • Tretli S, Engeland A, Haldorsen T, Hakulinen T, Horte LG, Luostarinen T, et al. Prostate cancer—look to Denmark?. J Natl Cancer Inst 1996; 88: 128
  • Brasso K, Iversen P. Prostate cancer in Denmark. Incidence, morbidity and mortality. Scand J Urol Nephrol Suppl 1999; 203: 29–33
  • Sheldon CA, Williams RD, Fraley EE. Incidental carcinoma of the prostate: a review of the literature and critical reappraisal of classification. J Urol 1980; 124: 626–31
  • Rohr LR. Incidental adenocarcinoma in transurethral resection of the prostate. Am J Surg Pathol 1987; 11: 53–8
  • Merrill RM, Feuer EJ, Warren JL, Schussler N, Stephenson RA. Role of transurethral resection of the prostate in population-based prostate cancer incidence rates. Am J Epidemiol 1999; 150: 848–60
  • Jack S, Geirsson G. Changes in treatment and cost of benign prostatic hyperplasia. Icelandic Med J 2001; 87: 213–8
  • Blomqvist P, Ekbom A, Carlsson P, Ahlstrand C, Johansson JE. Benign prostatic hyperplasia in Sweden 1987 to 1994: changing patterns of treatment, changing patterns of cost. Urology ;50 1987; 1997: 214–20
  • Brasso K, Friis S, Kruger SK, Jörgensen T, Iversen P. Prostate cancer in Denmark: a 50-year population-based study. Urology 1998; 51: 590–4
  • Garraway WM, Alexander FE. Prostate disease: epidemiology, natural history and demographic shifts. Br J Urol 1997; 79(Suppl 2)3–9
  • Brewster DH, Fraser LA, Harris V, Black RJ. Rising incidence of prostate cancer in Scotland: increased risk or increased detection?. BJU Int 2000; 85: 463–73
  • Egevad L, Granfors T, Karlberg L, Bergh A, Stattin P. Prognostic value of the Gleason score in prostate cancer. BJU Int 2002; 89: 538–42
  • Lau WK, Blute ML, Bostwick DG, Weaver AL, Sebo TJ, Zincke H. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4. J Urol 2001; 166: 1692–7
  • Merrill RM, Bird JS. Effect of young age on prostate cancer survival: a population-based assessment (United States). Cancer Causes Control 2002; 13: 435–43
  • Adami HO, Norlén BJ, Malker B, Meirik O. Long-term survival in prostatic carcinoma, with special reference to age as a prognostic factor. Scand J Urol Nephrol 1986; 20: 107–12
  • Bill-Axelson A, Holmberg L, Ruutu M, Haggmann M, Andersson SO, Bratell S, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005; 352: 1977–84
  • Johansson JE, Holmberg L, Johansson S, Bergström R, Adami HO. Fifteen-year survival in prostate cancer; a prospective, population-based study in Sweden. JAMA 1997; 277: 467–71
  • Sandblom G, Dufmats M, Varenhorst E. Long-term survival in a Swedish population-based cohort of men with prostate cancer. Urology 2000; 56: 442–7
  • Johansson JE, Andren O, Andersson SO, Dickman PW, Holmberg L, Magnuson A, et al. Natural history of early, localized prostate cancer. JAMA 2004; 291: 2713–19
  • Aus G, Hugosson J, Norlén L. Long-term survival and mortality in prostate cancer treated with noncurative intent. J Urol 1995; 154: 460–5
  • Brasso K, Friis S, Juel K, Jörgensen T, Iversen P. Mortality of patients with clinically localized prostate cancer treated with observation for 10 years or longer: a population based registry study. J Urol 1999; 161: 524–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.